Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-FR | Version v9-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-04-28 | 2020-02-17 |
| Drug Identification Number | 02444267 | 02444267 |
| Brand name | VARITHENA | VARITHENA |
| Common or Proper name | Polidocanol 1% Injectable Foam | Polidocanol 1% Injectable Foam |
| Company Name | PROVENSIS LTD | PROVENSIS LTD |
| Ingredients | POLIDOCANOL | POLIDOCANOL |
| Strength(s) | 1.3MG | 1.3MG |
| Dosage form(s) | FOAM | FOAM |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 18ml | 18ml |
| ATC code | C05BB | C05BB |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2020-01-01 | 2019-02-01 |
| Actual start date | 2020-02-17 | 2019-02-01 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Boston Scientific Corporation are continuing to assess whilst increasing capacity for production of the Drug Product | Following acquisition by Boston Scientific Corporation, the previous BTG’s decision to cease supply of the product is being reassessed |
| Health Canada comments | Dates prior to January 2020 are not able to be backdated |